DNA-guided CRISPR system targets RNA and expands Cas12 beyond gene editing
A DNA-guided CRISPR platform could make RNA detection and control more stable, scalable, and precise, opening new routes…
New mechanism to enhance precision in cancer drug development
Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects…
Atomic-level images could improve future COVID-19 antiviral drug design
The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more…
Metformin targets the gut instead of the liver to lower glucose
For decades, physicians and scientists thought metformin, the leading Type 2 diabetes medication taken by millions worldwide, mainly…
Human telomerase shows limited function across different animal species
A new research paper was published in Volume 18 of Aging-US on April 13, 2026, titled “Cross species activity of TERT…
Earliest Organisms on Earth Built Their Biochemistry around Molybdenum, Study Suggests
New research reveals that 3.4 billion years ago (Archean Eon), ancient microbes relied on molybdenum — a metal…
Glucose acts as a metabolic signal for myelin development
Researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have uncovered a surprising…
Study links polyploid cancer cells to tumor invasion and spread
One of the biggest challenges in cancer research is understanding why some tumor cells become especially aggressive, invasive…
APC-deficient cancer cells rely on single enzyme for survival
A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival,…
Mitochondrial activity keeps dendritic cells ready to fight disease
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) show that active mitochondria maintain dendritic cells,…
Study explains why current BET inhibitors fail in cancer treatment
For over a decade, a class of drugs called BET inhibitors has been tested in cancer trials with…
Metabolic pathways drive progression from pancreatic lesions to cancer
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate.…